カテゴリ： GlobalData, アメリカ, 企業調査

UnitedHealth Group Inc (UNH)：製薬・医療：M&Aディール及び事業提携情報

◆英語タイトル：UnitedHealth Group Inc (UNH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA904C9933
◆発行会社（調査会社）：GlobalData
◆発行日：2018年11月
◆ページ数：92
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
UnitedHealth Group Inc (UnitedHealth Group) is a diversified health care company. It offers health care services and products through two distinct platforms, namely UnitedHealthcare and Optum. Its UnitedHealthcare platform provides health care coverage and benefit services; and Optum platform provides information and technology-enabled health services. UnitedHealth Group offers health coverage, medicare plans, short-term health insurance and medicaid plans for individuals and families; health management and global health solutions for employers; health care network, value-based care; and clinician resources for physicians and health care professionals; and resources for brokers and consultants. The company offers its solutions and services to its members in the US and other countries. UnitedHealth Group is headquartered in Minnesota, the US.

UnitedHealth Group Inc (UNH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
UnitedHealth Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
UnitedHealth Group Inc, Medical Devices Deals, 2012 to YTD 2018 11
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deal Details 14
Venture Financing 14
Auburn Surgical To Raise US$0.25 Million In Venture Financing 14
Joliet Surgery Center To Raise US$0.7 Million In Venture Financing 15
Danbury Surgical Center To Raise US$0.3 Million In Venture Financing 16
Paoli Surgery Center To Raise US$0.85 Million In Venture Financing 17
Greenville Surgery Center To Raise US$0.18 Million In Venture Financing 18
Northern Rockies Surgery Center To Raise US$0.4 Million In Venture Financing 19
Treasure Valley Surgery Center Raises US$0.1 Million In Venture Financing 20
Channel Islands Surgicenter To Raise US$1 Million In Venture Financing 21
Loyola Ambulatory Surgery Center To Raise US$0.25 Million In Venture Financing 22
Golden Triangle SurgiCenter To Raise US$1 Million In Venture Financing 23
Audax Health Raises US$21 Million In Venture Financing 24
Hays Surgery Raises US$0.7 Million In Venture Financing 25
Partnerships 26
MemorialCare Medical Foundation Forms Joint Venture With Surgical Care Affiliates 26
Health Inventures Enters Into Distribution Agreement With Medline 28
UnitedHealthcare Partners With American Gastroenterological Association To Improve Patient Care 29
Equity Offering 30
Surgical Care Affiliates Completes IPO For US$188.6 Million 30
Debt Offering 32
Surgical Care Affiliates Raises USD250 Million in Private Placement of 6% Notes Due 2023 32
UnitedHealth Completes Public Offering Of Notes Due 2042 For US$625 Million 33
UnitedHealth Completes Public Offering Of Notes Due 2023 For US$625 Million 35
UnitedHealth Completes Public Offering Of Notes Due 2015 For US$625 Million 37
UnitedHealth Completes Public Offering Of Notes Due 2017 For US$625 Million 39
Family HealthCare Network Completes Private Placement Of Revenue Bonds For US$5 Million 41
Asset Transactions 42
WellCare Health Completes Acquisition Of Medicaid Business Of UnitedHealth 42
Acquisition 44
UnitedHealthcare to Acquire Peoples Health 44
Optum Acquires Alere Health for USD600 Million 45
UnitedHealth Acquires Catamaran for USD12.8 Billion 47
OptumRx Acquires Catamaran 49
Catamaran Acquires Healthcare Solutions for USD405 Million 51
Optum Acquires MedExpress Urgent Care 52
Optum Acquires Majority Stake In Audax Health 53
Healthcare Solutions Acquires Modern Medical 54
Surgical Care Acquires Health Inventures, Surgical And Physician Services Company 55
UnitedHealth Completes Acquisition Of Additional 24.68% Stake In Amil Participacoes For US$1.4 Billion 56
UnitedHealthcare Completes Acquisition Of XLHealth, Healthcare Services Company 58
UnitedHealth Group Inc – Key Competitors 59
UnitedHealth Group Inc – Key Employees 60
UnitedHealth Group Inc – Locations And Subsidiaries 62
Head Office 62
Other Locations & Subsidiaries 62
Recent Developments 65
Financial Announcements 65
Oct 16, 2018: UnitedHealth Group Reports 2018 Third Quarter Results 65
Jul 17, 2018: UnitedHealth reports second quarter results -2018 67
Apr 17, 2018: UnitedHealth Group Reports First Quarter Results 69
Jan 16, 2018: UnitedHealth Group Reports 2017 Results Highlighted by Continued Strong and Diversified Growth 71
Oct 17, 2017: UnitedHealth Group Third Quarter Highlights 73
Jul 18, 2017: UnitedHealth Group Second Quarter Highlights 74
Apr 18, 2017: UnitedHealth Group First Quarter Highlights 75
Jan 17, 2017: UnitedHealth Group Reports 2016 Results Highlighted by Continued Strong and Diversified Growth 76
Corporate Communications 78
Oct 09, 2018: UnitedHealthcare and Optum Support People in Georgia Preparing for Hurricane Michael 78
Oct 09, 2018: UnitedHealthcare and Optum Support People in Alabama Preparing for Hurricane Michael 79
Oct 09, 2018: UnitedHealthcare and Optum Support People in Florida Preparing for Hurricane Michael 80
Aug 16, 2017: UnitedHealth Group Announces New Leadership Roles 81
Aug 07, 2017: UnitedHealth Group Names Two New Directors 82
Jan 17, 2017: UnitedHealth Group appoints Timothy P. Flynn to board of directors 83
Legal and Regulatory 84
Jul 13, 2017: Zuckerman Spaeder Files Class Action Complaint Against UnitedHealth Group For Violation Of Mental Health Parity Laws 84
Government and Public Interest 85
May 11, 2018: UnitedHealth Group Statement on Trump Administration’s Drug Policy Proposal[TOPC : Pharma - UnitedHealth Group Inc] 85
Product News 86
Sep 14, 2017: UnitedHealthcare and DrFirst set out to change the drug prescribing experience 86
Other Significant Developments 87
Oct 31, 2018: UnitedHealthcare’s new and enhanced Digital Health resources help empower people to more effectively use their benefits and curb health care costs 87
Oct 28, 2018: Unitedhealth Group supporting people affected by mass shooting at Pittsburgh Synagogue 88
Jul 20, 2018: Unitedhealthcare and Optum take action to support people affected by tornadoes in central iowa 89
Jul 12, 2018: Benefit Assist Program Makes Benefit Payouts Faster and Easier for Employees Enrolled in Medical and Supplemental Health Plans 90
May 09, 2018: UnitedHealthcare’s Value-Based Care Program for Knee, Hip and Spine Procedures Demonstrates Improved Health Outcomes and Reduced Costs 91
Appendix 92
Methodology 92
About GlobalData 92
Contact Us 92
Disclaimer 92

List of Tables
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
UnitedHealth Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
UnitedHealth Group Inc, Deals By Therapy Area, 2012 to YTD 2018 10
UnitedHealth Group Inc, Medical Devices Deals, 2012 to YTD 2018 11
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Auburn Surgical To Raise US$0.25 Million In Venture Financing 14
Joliet Surgery Center To Raise US$0.7 Million In Venture Financing 15
Danbury Surgical Center To Raise US$0.3 Million In Venture Financing 16
Paoli Surgery Center To Raise US$0.85 Million In Venture Financing 17
Greenville Surgery Center To Raise US$0.18 Million In Venture Financing 18
Northern Rockies Surgery Center To Raise US$0.4 Million In Venture Financing 19
Treasure Valley Surgery Center Raises US$0.1 Million In Venture Financing 20
Channel Islands Surgicenter To Raise US$1 Million In Venture Financing 21
Loyola Ambulatory Surgery Center To Raise US$0.25 Million In Venture Financing 22
Golden Triangle SurgiCenter To Raise US$1 Million In Venture Financing 23
Audax Health Raises US$21 Million In Venture Financing 24
Hays Surgery Raises US$0.7 Million In Venture Financing 25
MemorialCare Medical Foundation Forms Joint Venture With Surgical Care Affiliates 26
Health Inventures Enters Into Distribution Agreement With Medline 28
UnitedHealthcare Partners With American Gastroenterological Association To Improve Patient Care 29
Surgical Care Affiliates Completes IPO For US$188.6 Million 30
Surgical Care Affiliates Raises USD250 Million in Private Placement of 6% Notes Due 2023 32
UnitedHealth Completes Public Offering Of Notes Due 2042 For US$625 Million 33
UnitedHealth Completes Public Offering Of Notes Due 2023 For US$625 Million 35
UnitedHealth Completes Public Offering Of Notes Due 2015 For US$625 Million 37
UnitedHealth Completes Public Offering Of Notes Due 2017 For US$625 Million 39
Family HealthCare Network Completes Private Placement Of Revenue Bonds For US$5 Million 41
WellCare Health Completes Acquisition Of Medicaid Business Of UnitedHealth 42
UnitedHealthcare to Acquire Peoples Health 44
Optum Acquires Alere Health for USD600 Million 45
UnitedHealth Acquires Catamaran for USD12.8 Billion 47
OptumRx Acquires Catamaran 49
Catamaran Acquires Healthcare Solutions for USD405 Million 51
Optum Acquires MedExpress Urgent Care 52
Optum Acquires Majority Stake In Audax Health 53
Healthcare Solutions Acquires Modern Medical 54
Surgical Care Acquires Health Inventures, Surgical And Physician Services Company 55
UnitedHealth Completes Acquisition Of Additional 24.68% Stake In Amil Participacoes For US$1.4 Billion 56
UnitedHealthcare Completes Acquisition Of XLHealth, Healthcare Services Company 58
UnitedHealth Group Inc, Key Competitors 59
UnitedHealth Group Inc, Key Employees 60
UnitedHealth Group Inc, Subsidiaries 62

List of Figures
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
UnitedHealth Group Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
UnitedHealth Group Inc, Medical Devices Deals, 2012 to YTD 2018 11

★海外企業調査レポート[UnitedHealth Group Inc (UNH)：製薬・医療：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • GE Power India Ltd：企業の戦略・SWOT・財務情報
    GE Power India Ltd - Strategy, SWOT and Corporate Finance Report Summary GE Power India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nemus Bioscience Inc (NMUS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Nemus Bioscience Inc (Nemus Bioscience) is a life-science and biopharmaceutical company that offers discovering, developing and commercializing cannabinoid-based therapeutics. The company’s drug pipeline products include NB1111, NB1222, NB2111, NB2222 and Cannabinoid platform NB3111. Its can …
  • AntriaBio Inc (ANTB)-製薬・医療分野：企業M&A・提携分析
    Summary AntriaBio Inc (AntriaBio), formerly AntriaBio Delaware Inc is a biopharmaceutical company that develops drug therapies for the treatment of diabetes and metabolic diseases. The company’s lead product candidate include AB10, human recombinant insulin for use in type 1 and type 2 diabetes for …
  • Compania Espanola de Petroleos SAU：企業の戦略的SWOT分析
    Compania Espanola de Petroleos SAU - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Integrated BioTherapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Integrated BioTherapeutics Inc (IBT) is a biotechnology company that discovers novel vaccines and therapeutics for infectious diseases. The company's products include polyclonal and monoclonal antibodies raised against emerging pathogens, pan-filovirus antibody candidates, vaccines and thera …
  • Outlook Therapeutics Inc (ONSIU)：企業の財務・戦略的SWOT分析
    Summary Outlook Therapeutics Inc (Outlook Therapeutics), formerly Oncobiologics Inc, is a biopharmaceutical company that develops, manufactures and commercializes biosimilar products in the areas of ophthalmology. The company is investigating its lead product candidate, ONS-5010 an ophthalmic formul …
  • Fuller, Smith & Turner Plc：企業の戦略・SWOT・財務分析
    Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report Summary Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Physio-Control Inc：医療機器：M&Aディール及び事業提携情報
    Summary Physio-Control Inc (Physio-Control), a subsidiary of Stryker Corp, is a manufacturer of emergency medical response products. The company offers lifepak monitor and defibrillator, lifepak CR plus AED, lifepak express AED, lifenet system, data review software, chest true cprcoaching device, lu …
  • China Sunergy Co., Ltd.：企業の戦略的SWOT分析
    China Sunergy Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Aeolus Pharmaceuticals Inc (AOLS)-製薬・医療分野：企業M&A・提携分析
    Summary Aeolus Pharmaceuticals Inc (Aeolus) is a biopharmaceutical company that is developing a platform of new compounds for use in cancer, infectious diseases, central nervous system (CNS) diseases, fibrosis and biodefense. The company’s lead product, AEOL 10150 is a broad catalytic antioxidant pa …
  • Kernel Holding SA：企業の戦略・SWOT・財務情報
    Kernel Holding SA - Strategy, SWOT and Corporate Finance Report Summary Kernel Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sulzer Ltd (SUN)：企業の財務・戦略的SWOT分析
    Sulzer Ltd (SUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • China Petroleum & Chemical Corp (600028)：石油・ガス：M&Aディール及び事業提携情報
    Summary China Petroleum & Chemical Corp (Sinopec Corp), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and gas exploration and production, extraction, pipeline transmission and marketing; oil refining; and production …
  • Linn Energy Inc (LNGG)：石油・ガス：M&Aディール及び事業提携情報
    Summary Linn Energy Inc (Linn Energy), formerly Linn Energy LLC, is an independent energy company. It explores for, develops, and produces oil, natural gas, and natural gas liquids (NGLs). The company has upstream assets in various operating regions in the US such as Hugoton Basin, the Mid-Continent …
  • Range Resources Corp (RRC)：企業の財務・戦略的SWOT分析
    Range Resources Corp (RRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Biogen, Inc.：戦略・SWOT・企業財務分析
    Biogen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Biogen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • IDInvest Partners：企業のM&A・事業提携・投資動向
    IDInvest Partners - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IDInvest Partners Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Tottenham Hotspur Ltd：企業の戦略的SWOT分析
    Tottenham Hotspur Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Chevron Corporation (CVX)：石油・ガス：M&Aディール及び事業提携情報
    Summary Chevron Corp (Chevron) is an integrated oil and gas company. It operates in the oil and gas value chain from exploration and production, storage and pipeline transportation to refining, marketing and distribution of oil and gas products. Chevron explores for, produces and transports crude oi …
  • Office Depot, Inc.：戦略・SWOT・企業財務分析
    Office Depot, Inc. - Strategy, SWOT and Corporate Finance Report Summary Office Depot, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆